SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 8, 2013, Pages 659-669

  Cao, L ^a   Liu, C ^a   Wang, F ^b   Wang, H ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Amyloid beta; Barrier integrity; Matrix metalloproteinase 9; SRT1720; Tight junction

Indexed keywords

AMYLOID BETA PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; SIRTUIN 1;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CELL VIABILITY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; PIGMENT EPITHELIUM; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPECTROPHOTOMETRY; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; BLOOD-RETINAL BARRIER; CELL SURVIVAL; ENZYME ASSAYS; GENE SILENCING; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MACULAR DEGENERATION; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PRIMARY CELL CULTURE; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES;

EID: 84883497243     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20132903     Document Type: Article

References (38)

1. Buschini E, Piras A, Nuzzi R, Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 2011; 95: 14-25, doi: 10.1016/ j.pneurobio.2011.05.011.
2. Johnson LV, Forest DL, Banna CD, Radeke CM, Maloney MA, Hu J, et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci U S A 2011; 108: 18277-18282, doi: 10.1073/pnas.1109703108.
3. Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest 2006; 116: 378-385, doi: 10.1172/JCI25843.
4. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835-846.
5. Isas JM, Luibl V, Johnson LV, Kayed R, Wetzel R, Glabe CG, et al. Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci 2010; 51: 1304-1310, doi: 10.1167/iovs.09-4207.
6. Jo DH, Kim JH, Kim JH. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness. Arch Pharm Res 2010; 33: 1557-1565, doi: 10.1007/ s12272-010-1007-6.
7. Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier. Eur J Ophthalmol 2011; 21 (Suppl 6): S3-S9, doi: 10.5301/ EJO.2010.6049.
8. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, Cheetham ME. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2004; 45: 675-684, doi: 10.1167/ iovs.03-0351.
9. Peng S, Gan G, Rao VS, Adelman RA, Rizzolo LJ. Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2012; 53: 5016-5028, doi: 10.1167/ iovs.11-8311.
10. Bruban J, Glotin AL, Dinet V, Chalour N, Sennlaub F, Jonet L, et al. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 2009; 8: 162-177, doi: 10.1111/j.1474-9726.2009.00456.x.
11. Cao L, Wang H, Wang F. Amyloid-beta-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption. Int J Mol Med 2013; 31: 1105-1112.
12. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 2002; 99: 11830-11835, doi: 10.1073/pnas.192203399.
13. Wang J, Ohno-Matsui K, Yoshida T, Kojima A, Shimada N, Nakahama K, et al. Altered function of factor I caused by amyloid beta: implication for pathogenesis of age-related macular degeneration from Drusen. J Immunol 2008; 181: 712-720.
14. Kurji KH, Cui JZ, Lin T, Harriman D, Prasad SS, Kojic L, et al. Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2010; 51: 1151-1163, doi: 10.1167/iovs.09-3622.
15. Jonas JB, Tao Y, Neumaier M, Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol 2012; 90: e381-e388, doi: 10.1111/j.1755-3768.2012.02414.x.
16. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293: 1653-1657, doi: 10.1126/science.1062374.
17. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380, doi: 10.1038/sj.emboj.7600244.
18. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191-196, doi: 10.1038/nature01960.
19. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486-489, doi:10.1126/ science.1079469.
20. Kivela T, Jaaskelainen J, Vaheri A, Carpen O. Ezrin, a membrane-organizing protein, as a polarization marker of the retinal pigment epithelium in vertebrates. Cell Tissue Res 2000; 301: 217-223, doi: 10.1007/s004410000225.
21. Villalba JM, Alcain FJ. Sirtuin activators and inhibitors. Biofactors 2012; 38: 349-359, doi: 10.1002/biof.1032.
22. Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, et al. Matrix metalloproteinase-2 and-9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One 2011; 6: e20599, doi: 10.1371/journal.pone.0020599.
23. Martins T, Baptista S, Goncalves J, Leal E, Milhazes N, Borges F, et al. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res 2011; 1411: 28-40.
24. Bauer AT, Burgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 2010; 30: 837-848, doi: 10.1038/ jcbfm.2009.248.
25. Nakamaru Y, Vuppusetty C, Wada H, Milne JC, Ito M, Rossios C, et al. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 2009; 23: 2810-2819, doi: 10.1096/fj.08-125468.
26. Li F, Gong Q, Dong H, Shi J. Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 2012; 18: 27-33, doi: 10.2174/138161212798919075.
27. Canevari L, Abramov AY, Duchen MR. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res 2004; 29: 637-650, doi: 10.1023/ B:NERE.0000014834.06405.af.
28. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015, doi: 10.1126/science.1094637.
29. Feng X, Liang N, Zhu D, Gao Q, Peng L, Dong H, et al. Resveratrol inhibits beta-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS One 2013; 8: e59888, doi: 10.1371/journal.-pone.0059888.
30. Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, et al. Resveratrol mitigates lipopolysaccharide-and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade. J Neurochem 2012; 120: 461-472, doi: 10.1111/j.1471-4159.2011.07594.x.
31. Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I. Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling. J Neurosci 2012; 32: 8845-8854, doi: 10.1523/ JNEUROSCI.6102-11.2012.
32. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683, doi: 10.1146/annurev.immunol.14.1.649.
33. Chen LF, Greene WC. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 2003; 81: 549-557, doi: 10.1007/ s00109-003-0469-0.
34. Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NFkappaB, JNK, and p38 MAPK signaling pathways in amyloid beta-stimulated microglia. Int Immunopharmacol 2012; 14: 13-20, doi: 10.1016/j.intimp.2012.06.003.
35. Walker DG, Lue LF, Beach TG. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 2001; 22: 957-966, doi: 10.1016/ S0197-4580(01)00306-2.
36. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-1560, doi: 10.1172/JCI113241.
37. Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995; 198: 1-24, doi: 10.1007/978-3-642-79414-8_1.
38. Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD. NFkappaB in aging and disease. Aging Dis 2011; 2: 449-465.